Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal dexamethasone for imminent preterm birth in resource-limited settings
ACTRN12617000476336Phase 3Terminated
- Sponsor
- World Health Organization
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in preterm birth, sponsored by World Health Organization. Primary endpoints: Neonatal death, Stillbirth or neonatal death and 1 more. Started Dec 2017; status: terminated.
02
Drugs
dexamethasone
03
Conditions
preterm birth
Beyond the preview
Go deeper on ACTRN12617000476336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000476336.